Characterization of human platelet binding of recombinant T cell receptor ligand.
about
p21-Activated kinase (PAK) regulates cytoskeletal reorganization and directional migration in human neutrophilsThe immunology of stroke: from mechanisms to translationGammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke.S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation.Characterization of the Rac guanine nucleotide exchange factor P-Rex1 in platelets.Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitisSystemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats.Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.Pivotal role for the mTOR pathway in the formation of neutrophil extracellular traps via regulation of autophagy.The PAK system links Rho GTPase signaling to thrombin-mediated platelet activationActivated factor XI inhibits chemotaxis of polymorphonuclear leukocytes.Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
P2860
Q27308144-758BA11B-C2B8-448A-83F8-FFB8D3601872Q29620066-039D6E9F-0870-427D-A4DB-8F278881AF50Q33404861-238856B9-752D-4C74-B184-E82755C24DA7Q34017153-5DF7E1B9-A860-44CA-8F1D-58A498333F51Q35220422-E21482D4-4286-45D3-BD35-957452A5E8DDQ35231317-13AC2AF2-D41C-4D29-B977-E36D6AE87804Q35893543-C0C6AC62-B6A8-4E73-9F56-674666D2C02FQ35946934-9BE029DF-589C-43C4-AC99-5DCC82917300Q36231789-DDCD9086-40F3-48EB-8A6B-D87494DC2FA1Q37022061-3EEE54FA-2AE9-4E72-B955-B20F384FA3C8Q37093598-F5F9D1ED-7402-45E5-91FA-8C6A8C880FAFQ37142347-D698AABE-4DCA-4792-9BAF-F5F4CCB8C401Q38911371-3083D275-3ADE-4B1F-ABB4-79F913379DA6Q38988985-E162D8A0-8E51-42AB-993B-749EBDE921CA
P2860
Characterization of human platelet binding of recombinant T cell receptor ligand.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Characterization of human platelet binding of recombinant T cell receptor ligand.
@ast
Characterization of human platelet binding of recombinant T cell receptor ligand.
@en
Characterization of human platelet binding of recombinant T cell receptor ligand.
@nl
type
label
Characterization of human platelet binding of recombinant T cell receptor ligand.
@ast
Characterization of human platelet binding of recombinant T cell receptor ligand.
@en
Characterization of human platelet binding of recombinant T cell receptor ligand.
@nl
prefLabel
Characterization of human platelet binding of recombinant T cell receptor ligand.
@ast
Characterization of human platelet binding of recombinant T cell receptor ligand.
@en
Characterization of human platelet binding of recombinant T cell receptor ligand.
@nl
P2093
P2860
P356
P1476
Characterization of human platelet binding of recombinant T cell receptor ligand
@en
P2093
Arthur A Vandenbark
Asako Itakura
Gregory G Burrows
Halina Offner
Ishan A Patel
Owen Jt McCarty
Roberto Meza-Romero
Tara C White-Adams
P2860
P2888
P356
10.1186/1742-2094-7-75
P577
2010-11-08T00:00:00Z
P5875
P6179
1052587501